Chapter/Section Purchase

1 Study Coverage
1.1 Tuberculosis Vaccine Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Tuberculosis Vaccine Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Tuberculosis Vaccine Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Tuberculosis Vaccine Treatment Sales by Region
2.4.1 Global Tuberculosis Vaccine Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Tuberculosis Vaccine Treatment by Region (2023-2028)
2.5 Global Tuberculosis Vaccine Treatment Revenue by Region
2.5.1 Global Tuberculosis Vaccine Treatment Revenue by Region (2017-2022)
2.5.2 Global Tuberculosis Vaccine Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturers
3.1.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tuberculosis Vaccine Treatment in 2021
3.2 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers
3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Revenue in 2021
3.3 Global Tuberculosis Vaccine Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Tuberculosis Vaccine Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tuberculosis Vaccine Treatment Sales by Type
4.1.1 Global Tuberculosis Vaccine Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Tuberculosis Vaccine Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2028)
4.2 Global Tuberculosis Vaccine Treatment Revenue by Type
4.2.1 Global Tuberculosis Vaccine Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Tuberculosis Vaccine Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Tuberculosis Vaccine Treatment Price by Type
4.3.1 Global Tuberculosis Vaccine Treatment Price by Type (2017-2022)
4.3.2 Global Tuberculosis Vaccine Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Tuberculosis Vaccine Treatment Sales by Application
5.1.1 Global Tuberculosis Vaccine Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Tuberculosis Vaccine Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2028)
5.2 Global Tuberculosis Vaccine Treatment Revenue by Application
5.2.1 Global Tuberculosis Vaccine Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Tuberculosis Vaccine Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Tuberculosis Vaccine Treatment Price by Application
5.3.1 Global Tuberculosis Vaccine Treatment Price by Application (2017-2022)
5.3.2 Global Tuberculosis Vaccine Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Vaccine Treatment Market Size by Type
6.1.1 North America Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
6.1.2 North America Tuberculosis Vaccine Treatment Revenue by Type (2017-2028)
6.2 North America Tuberculosis Vaccine Treatment Market Size by Application
6.2.1 North America Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
6.2.2 North America Tuberculosis Vaccine Treatment Revenue by Application (2017-2028)
6.3 North America Tuberculosis Vaccine Treatment Market Size by Country
6.3.1 North America Tuberculosis Vaccine Treatment Sales by Country (2017-2028)
6.3.2 North America Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Tuberculosis Vaccine Treatment Market Size by Type
7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Type (2017-2028)
7.2 Europe Tuberculosis Vaccine Treatment Market Size by Application
7.2.1 Europe Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
7.2.2 Europe Tuberculosis Vaccine Treatment Revenue by Application (2017-2028)
7.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
7.3.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2017-2028)
7.3.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Type
8.1.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Application
8.2.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Region
8.3.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Tuberculosis Vaccine Treatment Market Size by Type
9.1.1 Latin America Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
9.1.2 Latin America Tuberculosis Vaccine Treatment Revenue by Type (2017-2028)
9.2 Latin America Tuberculosis Vaccine Treatment Market Size by Application
9.2.1 Latin America Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
9.2.2 Latin America Tuberculosis Vaccine Treatment Revenue by Application (2017-2028)
9.3 Latin America Tuberculosis Vaccine Treatment Market Size by Country
9.3.1 Latin America Tuberculosis Vaccine Treatment Sales by Country (2017-2028)
9.3.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Type
10.1.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Application
10.2.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country
10.3.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Japan BCG Lab
11.2.1 Japan BCG Lab Corporation Information
11.2.2 Japan BCG Lab Overview
11.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Japan BCG Lab Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Corporation Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 AJ Vaccines
11.4.1 AJ Vaccines Corporation Information
11.4.2 AJ Vaccines Overview
11.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AJ Vaccines Recent Developments
11.5 BioFarma
11.5.1 BioFarma Corporation Information
11.5.2 BioFarma Overview
11.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BioFarma Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioFarma Recent Developments
11.6 GreenSignal Bio Pharma
11.6.1 GreenSignal Bio Pharma Corporation Information
11.6.2 GreenSignal Bio Pharma Overview
11.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GreenSignal Bio Pharma Recent Developments
11.7 China National Biotec
11.7.1 China National Biotec Corporation Information
11.7.2 China National Biotec Overview
11.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 China National Biotec Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 China National Biotec Recent Developments
11.8 Biomed Lublin
11.8.1 Biomed Lublin Corporation Information
11.8.2 Biomed Lublin Overview
11.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biomed Lublin Recent Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Corporation Information
11.9.2 Taj Pharmaceuticals Overview
11.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taj Pharmaceuticals Recent Developments
11.10 Ataulpho de Paiva
11.10.1 Ataulpho de Paiva Corporation Information
11.10.2 Ataulpho de Paiva Overview
11.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ataulpho de Paiva Recent Developments
11.11 IVAC
11.11.1 IVAC Corporation Information
11.11.2 IVAC Overview
11.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 IVAC Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 IVAC Recent Developments
11.12 Queen Saovabha Mem. Inst
11.12.1 Queen Saovabha Mem. Inst Corporation Information
11.12.2 Queen Saovabha Mem. Inst Overview
11.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Queen Saovabha Mem. Inst Recent Developments
11.13 Microgen
11.13.1 Microgen Corporation Information
11.13.2 Microgen Overview
11.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Microgen Tuberculosis Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Microgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tuberculosis Vaccine Treatment Industry Chain Analysis
12.2 Tuberculosis Vaccine Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tuberculosis Vaccine Treatment Production Mode & Process
12.4 Tuberculosis Vaccine Treatment Sales and Marketing
12.4.1 Tuberculosis Vaccine Treatment Sales Channels
12.4.2 Tuberculosis Vaccine Treatment Distributors
12.5 Tuberculosis Vaccine Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Tuberculosis Vaccine Treatment Industry Trends
13.2 Tuberculosis Vaccine Treatment Market Drivers
13.3 Tuberculosis Vaccine Treatment Market Challenges
13.4 Tuberculosis Vaccine Treatment Market Restraints
14 Key Findings in The Global Tuberculosis Vaccine Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer